DiabetologyNews.net

Diabetology Xagena

Search results for "Metformin"

Patients with type 2 diabetes who take Metformin seem to be at lower risk of cancer than those not treated with Metformin. Metformin, widely given to patients with type 2 diabetes, works by reduci ...


Exenatide ( Byetta ) reduced HbA1c with no weight gain and no increased incidence of hypoglycemia in patients with type 2 diabetes failing to achieve glycemic control with Metformin. Exenatide is t ...


FDA ( Food and Drug Administration ) has approved Exenatide ( Byetta ), also known as synthetic exendin-4, injection as adjunctive therapy to improve blood sugar control in patients with type 2 diabet ...


Clinical trials suggest that Rosiglitazone ( Avandia ), a drug that helps control blood glucose levels, may also reduce blood pressure in people with type 2 diabetes. According to the American Hear ...


A Phase III study showed Muraglitazar ( Pargluva ) 5 mg reduced A1C levels significantly more than Pioglitazone ( Actos ) 30 mg in patients with type 2 diabetes. Both treatment groups were taking M ...


Rimonabant ( Acomplia ) has demonstrated that it can lower blood glucose and reduce weight and waist circumference, as well as modify lipids associated with diabetic dyslipidemia, in patients with typ ...


Results from a study indicating that Exenatide ( Byetta ) injection showed sustained improvements in blood glucose control and progressive weight reduction through a year and a half of therapy for peo ...


Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program ( DPP ). Diabetic retinopathy, which can lead to vision loss, was also seen i ...


Research suggests that the investigational drug Vildagliptin ( Galvus ) improves the function of pancreatic islets in both animals and humans. Improved pancreatic islet function is a long-standing go ...


Results from three Phase II studies showed that Sitagliptin ( Januvia ), an investigational medicine in a potentially new class of agents for the treatment for diabetes called DPP-IV ( dipeptidyl pep ...


Results from a study indicate that Exenatide injection ( Byetta ) improves blood glucose levels as effectively as Insulin Glargine ( Lantus ) for patients with type 2 diabetes failing to achieve accep ...


The study was designed to assess the safety, tolerability and pharmacokinetics of Exenatide ( Byetta ) LAR (long-acting release ) given once a week. After 15 weeks, both doses of Exenatide LAR were ...


Researchers reported that in a two-year, controlled study people with type 2 diabetes receiving Starlix ( Nateglinide ) in combination with Metformin experienced equivalent levels of overall blood glu ...


Data from the PROactive Study, presented at the 41st meeting of the European Association for the Study of Diabetes ( EASD ) in Athens, demonstrated that Actos ( Pioglitazone ) significantly reduces t ...


Losing a modest amount of weight through dietary changes and increased physical activity reduces the occurrence of urinary incontinence in women with prediabetes. This finding comes from a new stud ...